These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Left ventricular diastolic function and exercise capacity in patients with Chagas cardiomyopathy. Lima MM; Nunes MC; Rocha MO; Beloti FR; Alencar MC; Ribeiro AL Echocardiography; 2010 May; 27(5):519-24. PubMed ID: 20412275 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of the Incremental Shuttle Walk Test in Chagas cardiomyopathy. Ávila MR; Figueiredo PHS; Lima VP; de Oliveira LFL; de Oliveira LFF; Silva WT; Trede Filho RG; de Carvalho Bastone A; Lacerda ACR; Mendonça VA; Mediano MFF; Costa HS Disabil Rehabil; 2022 Dec; 44(24):7516-7521. PubMed ID: 34613873 [TBL] [Abstract][Full Text] [Related]
12. Physical training improves exercise tolerance, cardiac function and promotes changes in neurotrophins levels in chagasic mice. Alves RL; Cardoso BRL; Ramos IPR; Oliveira BDS; Dos Santos ML; de Miranda AS; de Almeida TCS; Vieira MAR; Machado FS; Ferreira AJ; de Avelar GF Life Sci; 2019 Sep; 232():116629. PubMed ID: 31276687 [TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911 [TBL] [Abstract][Full Text] [Related]
14. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. Nunes MC; Barbosa MM; Ribeiro AL; Barbosa FB; Rocha MO J Neurol Sci; 2009 Mar; 278(1-2):96-101. PubMed ID: 19162278 [TBL] [Abstract][Full Text] [Related]
15. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706 [TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor. Pereira Nunes Mdo C; Barbosa MM; Ribeiro AL; Amorim Fenelon LM; Rocha MO Rev Esp Cardiol; 2010 Jul; 63(7):788-97. PubMed ID: 20609312 [TBL] [Abstract][Full Text] [Related]
17. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. Nunes MC; Barbosa MM; Ribeiro AL; Colosimo EA; Rocha MO J Am Soc Echocardiogr; 2009 Jan; 22(1):82-8. PubMed ID: 19131007 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors in Severe Chagasic Heart Failure. Costa SA; Rassi S; Freitas EMDM; Gutierrez NDS; Boaventura FM; Sampaio LPDC; Silva JBM Arq Bras Cardiol; 2017 Mar; 108(3):246-254. PubMed ID: 28443956 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F; J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]